Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123932232 | 12393223 | 2 | F | 20140512 | 20160829 | 20160523 | 20160901 | EXP | US-PFIZER INC-2016267946 | PFIZER | 55.00 | YR | M | Y | 0.00000 | 20160901 | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123932232 | 12393223 | 1 | PS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | UNK, WEEKLY (ONCE A WEEK) | U | 85635 | SOLUTION FOR INJECTION | /wk | ||||||||
123932232 | 12393223 | 2 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | UNK, WEEKLY (ONCE A WEEK) | U | 0 | /wk | |||||||||
123932232 | 12393223 | 3 | C | NISOLDIPINE. | NISOLDIPINE | 1 | UNK | 0 | |||||||||||
123932232 | 12393223 | 4 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
123932232 | 12393223 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
123932232 | 12393223 | 6 | C | ATENOLOL-CHLORTHALIDONE | 2 | UNK | 0 | ||||||||||||
123932232 | 12393223 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 | |||||||||||
123932232 | 12393223 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
123932232 | 12393223 | 9 | C | MOMETASONE | MOMETASONE | 1 | UNK | 0 | |||||||||||
123932232 | 12393223 | 10 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123932232 | 12393223 | 1 | Hormone replacement therapy |
123932232 | 12393223 | 2 | Hormone replacement therapy |
123932232 | 12393223 | 3 | Hypertension |
123932232 | 12393223 | 4 | Ischaemic heart disease prophylaxis |
123932232 | 12393223 | 5 | Blood pressure abnormal |
123932232 | 12393223 | 6 | Blood pressure abnormal |
123932232 | 12393223 | 7 | Respiratory tract congestion |
123932232 | 12393223 | 8 | Hypersensitivity |
123932232 | 12393223 | 9 | Respiratory tract congestion |
123932232 | 12393223 | 10 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123932232 | 12393223 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123932232 | 12393223 | Anxiety | |
123932232 | 12393223 | Blindness | |
123932232 | 12393223 | Cerebrovascular accident | |
123932232 | 12393223 | Emotional distress | |
123932232 | 12393223 | Retinal vein occlusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123932232 | 12393223 | 1 | 201401 | 20140512 | 0 | |
123932232 | 12393223 | 2 | 201207 | 201401 | 0 | |
123932232 | 12393223 | 3 | 2006 | 0 | ||
123932232 | 12393223 | 4 | 2006 | 0 | ||
123932232 | 12393223 | 5 | 2006 | 0 | ||
123932232 | 12393223 | 6 | 2006 | 0 | ||
123932232 | 12393223 | 7 | 2006 | 0 | ||
123932232 | 12393223 | 9 | 2006 | 0 | ||
123932232 | 12393223 | 10 | 2006 | 0 |